Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Berberine has showed effective in lowering blood sugar levels in db/db mice and
anti-dyslipidemia in human. These findings have not been tested in a clinical trial. This
randomized, double blind, placebo controlled and multi-center study has demonstrated that
berberine is effective in lowering plasma glucose concentrations, reducing serum HbA1c and
anti-dyslipidemia in type 2 diabetic patients with dyslipidemia.